Treatment of Overactive Bladder With Anticholinergic Agents

Evaluation of Anticholinergic Treatment Response and Predictive Factors in Pediatric Overactive Bladder

This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.

A total of approximately 150 patients with overactive bladder will be evaluated retrospectively. Clinical and demographic data and voiding diaries of these patients will be evaluated. For this purpose, patients will be divided into mainly three groups according to the anticholinergic agent used.

Inclusion Criteria:

• Patients diagnosed with overactive bladder
• Patients treated with an anticholinergic

Exclusion Criteria:

• Presence of anatomical or neurological problems
• Patients with missing data